|
MTERFD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.87258999999607E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.449900E-04 |
| Normal-vs-Stage2 |
1.956000E-03 |
| Normal-vs-Stage3 |
4.28279999999948E-05 |
| Normal-vs-Stage4 |
2.39679999999298E-05 |
| Stage1-vs-Stage2 |
6.626400E-01 |
| Stage1-vs-Stage3 |
1.328990E-01 |
| Stage1-vs-Stage4 |
1.248420E-01 |
| Stage2-vs-Stage3 |
4.513200E-01 |
| Stage2-vs-Stage4 |
3.723000E-01 |
| Stage3-vs-Stage4 |
8.866800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.82118999999537E-05 |
| Normal-vs-AfricanAmerican |
4.029000E-04 |
| Normal-vs-Asian |
6.556300E-02 |
| Caucasian-vs-AfricanAmerican |
3.400400E-01 |
| Caucasian-vs-Asian |
1.310980E-01 |
| AfricanAmerican-vs-Asian |
7.147600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.87770000000499E-05 |
| Normal-vs-Female |
3.75400000000026E-05 |
| Male-vs-Female |
6.846000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.196200E-03 |
| Normal-vs-Age(41-60Yrs) |
4.47240000034377E-07 |
| Normal-vs-Age(61-80Yrs) |
2.720600E-03 |
| Normal-vs-Age(81-100Yrs) |
1.922040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.636400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.443800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.756400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.033800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.435600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.419400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.169800E-02 |
| Classical-VS-Follicular |
7.242600E-01 |
| Classical-VS-Other |
9.319800E-01 |
| Classical-VS-Normal |
8.617300E-04 |
| Tall-VS-Follicular |
4.963600E-02 |
| Tall-VS-Other |
3.810400E-01 |
| Tall-VS-Normal |
8.21370000000377E-05 |
| Follicular-VS-Other |
8.590400E-01 |
| Follicular-VS-Normal |
1.665730E-02 |
| Other-VS-Normal |
1.544380E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.58409999999809E-05 |
| Normal-vs-N1 |
4.543800E-03 |
| N0-vs-N1 |
7.219000E-01 |
|
|
